Becker M - Search Results

1

Assistive Device for Efficient Intravitreal Injections.

Ullrich F, Michels S, Lehmann D, Pieters RS, Becker M, Nelson BJ. Ullrich F, et al. Among authors: becker m. Ophthalmic Surg Lasers Imaging Retina. 2016 Aug 1;47(8):752-62. doi: 10.3928/23258160-20160808-09. Ophthalmic Surg Lasers Imaging Retina. 2016. PMID: 27548453 Review.

2

Clinical Experience With the First Commercially Available Intraoperative Optical Coherence Tomography System.

Pfau M, Michels S, Binder S, Becker MD. Pfau M, et al. Among authors: becker md. Ophthalmic Surg Lasers Imaging Retina. 2015 Nov-Dec;46(10):1001-8. doi: 10.3928/23258160-20151027-03. Ophthalmic Surg Lasers Imaging Retina. 2015. PMID: 26599241

3

A Magnetically Navigated Microcannula for Subretinal Injections.

Charreyron SL, Boehler Q, Danun AN, Mesot A, Becker M, Nelson BJ. Charreyron SL, et al. Among authors: becker m. IEEE Trans Biomed Eng. 2021 Jan;68(1):119-129. doi: 10.1109/TBME.2020.2996013. Epub 2020 Dec 21. IEEE Trans Biomed Eng. 2021. PMID: 32746007

4

Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration.

Mazaraki K, Fassnacht-Riederle H, Blum R, Becker M, Michels S. Mazaraki K, et al. Among authors: becker m. Br J Ophthalmol. 2015 Oct;99(10):1341-4. doi: 10.1136/bjophthalmol-2015-306636. Epub 2015 Apr 15. Br J Ophthalmol. 2015. PMID: 25877895 Free PMC article.

5

IMPACT OF LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR ON PREEXISTING MICROSTRUCTURAL ALTERATIONS IN DIABETIC MACULAR EDEMA.

Wirth MA, Wons J, Freiberg FJ, Becker MD, Michels S. Wirth MA, et al. Retina. 2018 Sep;38(9):1824-1829. doi: 10.1097/IAE.0000000000001788. Retina. 2018. PMID: 28767550 Free article.

6

Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion.

Pfau M, Fassnacht-Riederle H, Becker MD, Graf N, Michels S. Pfau M, et al. Among authors: becker md. Ophthalmic Res. 2015;54(3):150-6. doi: 10.1159/000439223. Epub 2015 Sep 29. Ophthalmic Res. 2015. PMID: 26413794

7

SYSTEMIC INTERLEUKIN 1β INHIBITION IN PROLIFERATIVE DIABETIC RETINOPATHY: A Prospective Open-Label Study Using Canakinumab.

Stahel M, Becker M, Graf N, Michels S. Stahel M, et al. Among authors: becker m. Retina. 2016 Feb;36(2):385-91. doi: 10.1097/IAE.0000000000000701. Retina. 2016. PMID: 26218500 Free PMC article.

8

LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study.

Freiberg FJ, Brynskov T, Munk MR, Sørensen TL, Wolf S, Wirth MA, Becker M, Michels S. Freiberg FJ, et al. Among authors: becker m. Retina. 2017 Dec;37(12):2341-2346. doi: 10.1097/IAE.0000000000001488. Retina. 2017. PMID: 28099318

9

COMPARISON OF RESOLUTION OF VITREOMACULAR TRACTION AFTER OCRIPLASMIN TREATMENT OR VITRECTOMY.

Scholz P, Sitnilska V, Hess J, Becker M, Michels S, Fauser S. Scholz P, et al. Among authors: becker m. Retina. 2019 Jan;39(1):180-185. doi: 10.1097/IAE.0000000000001926. Retina. 2019. PMID: 29135889

10

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD.

Fassnacht-Riederle H, Becker M, Graf N, Michels S. Fassnacht-Riederle H, et al. Among authors: becker m. Graefes Arch Clin Exp Ophthalmol. 2014 Nov;252(11):1705-9. doi: 10.1007/s00417-014-2589-3. Epub 2014 Mar 11. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24614949 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,942 results

Search Page